Log in to save to my catalogue

Meta-analysis of cognitive behaviour therapy and selective serotonin reuptake inhibitors for the tre...

Meta-analysis of cognitive behaviour therapy and selective serotonin reuptake inhibitors for the tre...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3f847fd65f6346608bd07cb636513e57

Meta-analysis of cognitive behaviour therapy and selective serotonin reuptake inhibitors for the treatment of hypochondriasis: Implications for trial design

About this item

Full title

Meta-analysis of cognitive behaviour therapy and selective serotonin reuptake inhibitors for the treatment of hypochondriasis: Implications for trial design

Publisher

New York: Elsevier Inc

Journal title

Comprehensive psychiatry, 2022-10, Vol.118, p.152334-152334, Article 152334

Language

English

Formats

Publication information

Publisher

New York: Elsevier Inc

More information

Scope and Contents

Contents

Classification of hypochondriasis as an obsessive-compulsive and related disorder in the International Classification of Diseases 11th Revision (ICD-11) has generated new heuristics for treatment of this common, chronic and disabling disorder. Standard treatment involves cognitive behaviour therapy (CBT) or selective serotonin reuptake inhibitors (...

Alternative Titles

Full title

Meta-analysis of cognitive behaviour therapy and selective serotonin reuptake inhibitors for the treatment of hypochondriasis: Implications for trial design

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3f847fd65f6346608bd07cb636513e57

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3f847fd65f6346608bd07cb636513e57

Other Identifiers

ISSN

0010-440X

E-ISSN

1532-8384

DOI

10.1016/j.comppsych.2022.152334

How to access this item